SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Xalles Holdings Inc. (XALL) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 36/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XALL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.02 |
$0.00 |
$-539.94K |
- |
| 2017 |
$0.00 |
$0.00 |
$-269.58K |
- |
| 2018 |
$0.00 |
$152.07K |
$-102.5K |
-67.4% |
| 2019 |
$0.00 |
$37.87K |
$-134.07K |
-354% |
| 2020 |
$0.00 |
$817.7K |
$325.2K |
39.8% |
| 2021 |
$0.00 |
$416.69K |
$-180.79K |
-43.4% |
| 2022 |
$0.00 |
$5.91M |
$1.08M |
18.3% |
| 2023 |
$0.00 |
$19.12M |
$2.79M |
14.6% |
| 2024 |
$0.00 |
$21.16M |
$433.71K |
2% |
| 2025 |
$0.00 |
$12.41M |
$-3.91M |
-31.5% |
